The Crohn’s & Colitis Foundation was selected as one of two patient organizations to participate in an U.S. Food & Drug Administration (FDA) Real-World Evidence Program demonstration project using the FDA MyStudies App through the FDA-Catalyst system. The FDA Real World Evidence Program will inform the assessment of the fitness for use of real-world data to support real-world evidence generation for ...
Read More »Colitis
Discovered interaction between bacteria and immune cells protects the intestinal barrier
An international study led by the Complutense University of Madrid (UCM) and the National Centre for Cardiovascular Research (CNIC) has found that Lactobacillusbacteria present in the intestinal microbiota interact with immune system cells to strengthen the intestinal barrier. Conducted on mice and published in Immunity, the study opens a new avenue for the treatment of diseases such as ulcerative colitis or Crohn’s ...
Read More »Novel PET imaging noninvasively pinpoints colitis inflammation sites
A novel positron emission tomography (PET) imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’s disease. The University of California, Los Angeles (UCLA), study is featured inThe Journal of Nuclear Medicine. The U.S. Centers for Disease Control states that approximately three million Americans reported being diagnosed ...
Read More »Study to compare the effectiveness of biologic or small molecule therapies in IBD receives funding
Crohn’s disease (CD) and ulcerative colitis (UC), collectively referred to as inflammatory bowel diseases (IBD), which may affect as many as 3 million Americans, cost over $6 billion annually, and cause substantial patient morbidity, missed work and school, and diminished quality of life. Currently, anti-TNF therapy is considered first line treatment for moderate-to-severe IBD. However, up to 80 percent of ...
Read More »AGA Launches New Patient App to Aid in Inflammatory Bowel Disease (IBD) Monitoring and Education
The American Gastroenterological Association (AGA) today announced the launch of My IBD Manager, a new digital patient resource developed for the 1.6 million Americans living with Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD), and the doctors who treat them. This will be followed by the launch of an online clinical platform for health care professionals, ...
Read More »